loader image
Close
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us
Menu
  • GMP
  • FDA Academy
  • Downloadables
  • Bids and Awards
  • Careers
  • FAQs
  • Report
  • Contact Us

  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Old Issuances
    • Old FDA Advisories
  • Services
    • eServices
    • ePortal
    • ePortal2
    • Doctrack
    • RRDportal
Menu
  • Home
  • About FDA
  • Transparency
  • Issuances
    • Advisories
    • Administrative Order
    • Executive Order
    • FDA Circular
    • FDA Memorandum
    • Memorandum Circular
    • Republic Act
    • Old Issuances
    • Old FDA Advisories
  • Services
    • eServices
    • ePortal
    • ePortal2
    • Doctrack
    • RRDportal

Category: Department Order

FDA Advisory No.2021-1403 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: 1. OTC Diclofenac Sodium Aerosol 2. OTC Terbinafine Hydrochloride Spray-Yansuan […]

Department Order No. 2017-0425 || Clarification on the Certificate Issued by the Food and Drug Administration Prior to the Issuance of a License to Operate a Hospital in the One Stop Shop Strategy

to continue reading download the attachment… Attachment:-> Department Order No. 2017-0425

Quick Menus

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts
  • Draft for Comments || Guidelines on Food and Drug Administration’s…

  • FDA Advisory No.2023-0163-A || Babala sa Publiko tungkol sa Paggamit…

  • FDA Advisory No.2023-0164-A || Babala sa Publiko Tungkol sa Pagbili…

  • FDA Advisory No.2023-0163 || Public Health Warning Against the Purchase…

Quick Links
  • Department of Health (DOH)
  • U.S Food and Drug Administration (U.S FDA)
  • Department of Information and Communications Technology (DICT)
  • Department of Science and Technology (DOST)
  • Anti-Red Tape Authority (ARTA)
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City
Tel. no: (02) 8857-1900 local 1000
[email protected]
 
 
 
Landline: 

(02) 8857-1900
l
ocal 1000
(02) 8842-5635

Mobile:

09617709691
09616845994
09610574926

Email: [email protected]

Copyright © 2023. All Rights Reserved.

Shares